AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)
AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)

Financial Summary TEVA Quote Teva Pharma

Teva Pharmaceutical Industries Limited American Depositary Shares Quote

Teva Pharmaceut (TEVA)

11.87 -0.02 Healthcare
Stock Performance rating :
Recommendation :
Not Available
Symbol TEVA
Price 11.87
Beta 1.32
Vol Avg 14.98 M
Mkt cap 15.67 B
Shares 961
Last Div Not Available
Div Yield 13.66%
DCF Unlevered Not Available Not Available
DCF Levered Not Available Not Available
ROE Not Available Not Available
ROA Not Available Not Available
Operating Margin Not Available Not Available
Debt/Equity Not Available Not Available
P/E Not Available Not Available
P/B Not Available Not Available
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 20,272 19,652 21,903 0 0
COGS 9,216 8,296 10,044 11,560 10,558
GrossProfit 11,056 11,356 11,859 10,825 8,296
Depreciation (included in COGS) 1,508 1,308 1,524 0 0
StockBasedCompe (included in COGS) 95 117 124 133 155
ResearchAndDeve 1,488 1,525 2,111 1,848 1,213
SalesGeneralAnd 5,078 4,717 5,096 4,986 4,214
OperatingIncome 4,490 5,114 4,652 4,013 2,889
InterestExpense 300 270 546 875 920
OtherIncome -552 -2,492 -3,282 -21,517 -4,565
IncomeBeforeTax 3,638 2,352 824 -18,379 -2,596
ProvisionForInc 0 0 0 0 0
NetIncome 3,055 1,588 329 -16,265 -2,150
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 2,226 6,946 988 963 1,782
ShortTermInvest 0 0 0 0 0
Cash 2,226 6,946 988 0 0
AccountReceivab 5,408 5,350 7,523 0 0
Inventories 4,371 3,966 4,954 0 0
DeferredIncomeT 0 0 725 574 368
OtherCurrentAss 1,398 1,401 2,134 1,267 560
TotalCurrentAss 14,396 18,398 16,961 15,382 13,794
PPE 9,880 10,073 11,926 12,178 11,796
AccumulatedDepr -3,345 -3,529 -3,853 -4,505 -4,928
NetPPE 6,535 6,544 8,073 7,673 6,868
EquityAndOtherI 0 0 0 0 0
Goodwill 18,408 19,025 44,409 28,414 24,917
IntangibleAsset 5,512 7,675 21,487 17,640 14,005
OtherLTAssets 1,569 2,616 1,235 932 731
TotalNonCurrent 32,024 35,860 75,929 55,233 46,889
TotalAssets 46,420 54,258 92,890 70,615 60,683
ShortTermDebt 1,761 1,585 3,276 3,646 2,216
AccountsPayable 0 0 2,157 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 0 3,405 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 10,528 11,420 9,681 9,192 8,385
TotalCurrentLia 12,289 13,005 18,519 17,921 14,322
Debt 8,566 8,383 32,524 0 0
DeferredTaxesLi 1,101 1,748 5,215 3,277 2,140
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 1,109 1,195 1,639 1,843 1,727
TotalNonCurrent 10,818 11,484 41,034 35,335 31,654
TotalLiabilitie 23,107 24,489 59,553 53,256 45,976
CommonStock 50 52 54 54 56
AdditionalPaidI 14,121 17,757 23,409 23,479 27,210
RetainedEarning 14,436 14,851 13,607 -3,803 -5,958
AccumulatedOthe -1,343 -1,955 -3,159 -1,853 -2,459
TotalStockholde 23,313 29,769 33,337 17,359 14,707
TotalLiabilitie 46,420 54,258 92,890 70,615 60,683
Cash Flow Statement
Year 20142015201620172018
NetIncome 3,055 1,588 329 -16,265 -2,150
Depreciation 1,508 1,308 1,524 0 0
DeferredIncomeT -226 237 15 -2,331 -837
StockBasedCompe 95 117 124 133 155
AccountsReceiva 710 763 343 514 88
InventoryCS 230 129 753 266 26
AccountsPayable 0 0 0 0 0
OtherWorkingCap -650 75 123 -1,143 -1,937
OtherNonCashIte 31 95 247 -519 -40
NetCashProvided 5,127 5,542 5,225 3,507 2,446
InvestmentsInPP -929 -772 -901 -874 -651
AcquisitionsNet -363 -3,309 -36,148 43 0
PurchasesOfInve -324 -2,003 -481 -200 -119
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 0 0
OtherInvestingA -30 -5 -212 -282 1,746
NetCashUsedForI -1,450 -5,565 -35,740 2,164 1,866
DebtIssued 0 2,099 25,252 506 4,434
DebtRepayment -839 -2,521 -999 -3,300 -7,446
CommonStockIssu 0 3,291 329 0 0
CommonStockRepu -500 -439 0 0 0
DividendPaid -1,156 -1,155 -1,558 -1,161 -22
OtherFinancingA 120 239 1,864 -1,795 -317
NetCashProvided -2,375 4,805 25,217 -5,750 -3,351
NetChangeInCash 1,188 4,720 -5,958 -25 819
CashAtBeginning 1,038 2,226 6,946 988 963
CashAtEndOfPeri 2,226 6,946 988 963 1,782
Retained Earnings
Year 20142015201620172018
RetainedEarning ---14,43614,851
NetIncome --3,0551,588329
StockDividend ---16,335-8482,473
DividendPaid ---1,156-1,155-1,558
RetainedEarning --14,43614,85113,607
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ---6,5356,544
DeprAnnual 0--3,345-184-324
CapitalExpendit 00929772901
NetPPE --6,5356,5448,073
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0--23,92026,700
Amortization 0-1,837-1,124-1,200
NewPurchases 0-22,0833,90440,396
intAndGW --23,92026,70065,896
Company Profile

CEO

Kare Schultz

Sector

Healthcare

Industry

Drug Manufacturers

Exchange

New York Stock Exchange

Description

Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.